ABSTRACT
Although commercial software exists for microarray data analysis, the flexibility and functionality of the software never catch up with the expanding diversity and changing subtlety of the biological aims of most research laboratories. The situation is true for epigenomics where innovative techniques are emerging. Novel analysis has to be devised for the developing technologies as well.
